API-CAT & IMPROVE

from OncoPharm · host John Bossaer

We discuss reduced dose apixaban for months 6+ of treating cancer-associated VTE (API-CAT) and the impact (or lack thereof) of pausing BTK-inhibitors around vaccination (IMPROVE)

Episode metadata supplied by the publisher feed · Published Apr 3, 2025

Embed this episode

Attribution link and audio player

Ready to play

API-CAT & IMPROVE

0:00 12:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncoPharm?

This episode is 12 minutes long.

When was this OncoPharm episode published?

This episode was published on April 3, 2025.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!